Signal
Compact type II-C Cas9 nucleases with expanded PAM access and high fidelity for therapeutic genome editing
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-08-17 22:28 UTCUpdated 2026-08-18 16:08 UTC
rss
virus
Trend in the last 24h
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Compact CRISPR nucleases are attractive for therapeutic genome editing because their small coding sequences facilitate delivery by adeno-associated virus.
Score total
1.02
Momentum 24h
3
Posts
3
Origins
1
Source types
1
Duplicate ratio
0%
All evidence
All evidence
Virus-like particle-delivered base editor collection to expand the genome engineering toolbox
bioRxiv (all subjects) · biorxiv.org · 2026-08-18 16:08 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 1Origin domains: 1Duplicates: -
Showing 1 / 0
Top publishers (this list)
- bioRxiv (all subjects) (1)
Top origin domains (this list)
- biorxiv.org (1)